Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Matinas Biopharma Holdings, Inc. (MTNB) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-24.25M |
|
-- |
|
-- |
|
$24.59M |
|
$-24.59M |
|
$0.26M |
|
$-24.33M |
|
$-24.33M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.59M |
|
$-23.64M |
|
4.87M |
|
4.87M |
|
$-4.98 |
|
$-4.98 |
|
| Balance Sheet Financials | |
$8.03M |
|
$0.47M |
|
$4.62M |
|
$12.64M |
|
$2.67M |
|
$0.01M |
|
$2.38M |
|
$5.05M |
|
$7.59M |
|
$7.59M |
|
$7.59M |
|
5.09M |
|
| Cash Flow Statement Financials | |
$-15.88M |
|
$9.21M |
|
$9.17M |
|
$5.04M |
|
$7.53M |
|
$2.50M |
|
$3.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.01 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-319.51% |
|
-319.51% |
|
-191.84% |
|
-319.01% |
|
$1.49 |
|
$-3.26 |
|
$-3.26 |
|